A comparative characteristic of the effectivity of using 3-oxipiridin as a complement to microbial eczema standard therapy

Abstract

77 patients with microbial eczema (male - 58 (75,3%), female - 19 (24,7%)) in aged from 16 to 78 years (average age - 41,33 ± 12,69 years) were observed. The research was provided with forms of information agreement. Derivative of 3-oxipiridin - emoxipine with antioxidant type of activity (20 patients) were used as a complement to standard therapy.
It was discovered: reduction of activity of lipid free radical oxidation and endogen intoxication syndrome, simultaneously activity of antioxidant defense increased. Combination of emoxipine made these processes more effective.
Clinical effectivity of emoxipine was showed: time of beginning of rash elements regress such as hospital treatment period decreased, simultaneously the percent of clinical recovery become shorter.